Mounjaro (tirzepatide) is a prescription medication for adults with type 2 diabetes. It is used in combination with diet and exercise to help improve blood sugar control. The 7.5mg dose is a key step-up from the initial treatment, providing a stronger therapeutic effect for patients who require additional support in managing their condition.
Mounjaro contains the active ingredient Tirzepatide, a unique dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This innovative dual action helps your body in several ways: - It stimulates the release of insulin only when your blood sugar levels are high, helping to control glucose spikes. - It reduces the amount of glucose produced by your liver. - It slows down how quickly food leaves your stomach, which helps you feel fuller for a longer period and can aid in reducing food cravings and appetite.